<doc>
  <docmeta id="113hr2148ih">
    <bill congress="113" type="hr" number="2148" version="ih"/>
    <revision size="4989" annotations="0" status="complete" id="3" commit-time="2013-06-28T16:57:48Z" committer="mbohmer" doc="113hr2148ih/3.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H5902804FF7B948C0882071E8543911FA" public-private="public">
	<metadata>
<dublinCore>
<title>113 HR 2148 IH: Synthetics are Dangerous Act of 2013</title>
<publisher>U.S. House of Representatives</publisher>
<date>2013-05-23</date>
<format>text/xml</format>
<language>EN</language>
<rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 2148</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130523">May 23, 2013</action-date>
			<action-desc>
        <sponsor name-id="C001072">Mr. Carson of Indiana</sponsor>
			 introduced the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Office of National Drug Control Policy
		  Reauthorization Act of 1998 to increase public awareness about the dangers of
		  synthetic drugs through the national youth antidrug media
		  campaign.</official-title>
	</form>
	<legis-body id="H3993B9285B11413FB34772DDE6447A76" style="OLC">
		<section id="H7FE5DC9C838E418D92D73F6559AD6940" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Synthetics are Dangerous Act of
			 2013</short-title>
        </quote>.</text>
		</section>
    <section id="H46F538E607C14239BF89B36AC4B1FAA8">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> finds as follows:</text>
			<paragraph id="HD60D6C6A77984579A7BF83EE875AD6AB">
        <enum>(1)</enum>
        <text>Synthetic drugs,
			 sometimes referred to as designer drugs, are chemical compounds produced in
			 clandestine laboratories to mimic or enhance the effects of schedule I
			 controlled substances such as methamphetamine, ecstasy, and marijuana.</text>
			</paragraph>
      <paragraph id="HCDD81A0529B14AF69F9058E653E7A242">
        <enum>(2)</enum>
        <text>Given the lack of
			 extensive medical research on many synthetic drugs and their various analogues,
			 the full scope of their harmful effects is not well understood.</text>
			</paragraph>
      <paragraph id="H2DD4ABE460E345B49D8710D93C99D0B4">
        <enum>(3)</enum>
        <text>The circumstantial
			 evidence of the harmful effects of synthetic drugs, particularly synthetic
			 cannabinoids (such as <quote>K2</quote> and <quote>spice</quote>) and synthetic
			 stimulants (such as <quote>bath salts</quote>) are, nevertheless,
			 alarming—</text>
				<subparagraph id="H6949568A72D847E48397B25291A9C009">
          <enum>(A)</enum>
          <text>in 2010, more than
			 11,000 individuals were admitted into the emergency room from complications
			 arising from synthetic drug use, and nearly 25 percent of those patients
			 required further medical treatment; and</text>
				</subparagraph>
        <subparagraph id="H513E062DDAC34E4FB96D8C4747C056D4">
          <enum>(B)</enum>
          <text>in 2011, the
			 American Association of Poison Control Centers reported more than a two-fold
			 increase in the number of calls related to synthetic marijuana from the
			 previous year.</text>
				</subparagraph>
      </paragraph>
      <paragraph id="H0777CB3AA7FD4D35B5F993FFAC146F8F">
        <enum>(4)</enum>
        <text>The harmful
			 effects of ingesting synthetic drugs include but are not limited to agitation,
			 anxiety, nausea, vomiting, tachycardia, elevated blood pressure, tremor,
			 seizures, hallucinations, paranoid behavior, and nonresponsiveness.</text>
			</paragraph>
      <paragraph id="HF22CAB7F6B2B465198CB99A2A66E15DF">
        <enum>(5)</enum>
        <text>Like all schedule
			 I drugs, these synthetic drugs are drugs that have a high potential for abuse,
			 have no medical use in the United States, and lack an accepted safe use.</text>
			</paragraph>
      <paragraph id="HB3B44734B95E45C6B54C51A22C1BFC3D">
        <enum>(6)</enum>
        <text>The passage of the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Synthetic Drug Abuse Prevention Act of 2012">Synthetic Drug Abuse Prevention Act of 2012</cato:entity-ref> was an important step in reducing
			 the access of teens and young adults to dangerous and addictive synthetic
			 drugs.</text>
			</paragraph>
      <paragraph id="H572E4F19E87F4CF6A8BF2B91C8D330C7">
        <enum>(7)</enum>
        <text>New synthetic
			 drugs are being manufactured that contain chemical compounds not found on
			 schedule I, as set forth in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:202/ss:c">section 202(c) of the Controlled Substances Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/812/c">21
			 U.S.C. 812(c)</cato:entity-ref>)</cato:entity>, that nevertheless mimic or enhance the effects of controlled
			 substances like methamphetamine, marijuana, ecstasy, and LSD.</text>
			</paragraph>
      <paragraph id="H23361BD21F094B3CACE2B388E6F2DB67">
        <enum>(8)</enum>
        <text>Hundreds,
			 potentially thousands, of teens and young adults will be admitted into
			 emergency rooms around the country from complications caused by the ingestion
			 of the next breed of harmful, synthetic drugs.</text>
			</paragraph>
      <paragraph id="HC1B5CE3367894D1483ABF687C1D4A353">
        <enum>(9)</enum>
        <text>It is the sense of
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> that there is an urgent need, particularly among teens, young
			 adults, and parents, to raise awareness about the dangers of these new
			 synthetic drugs.</text>
			</paragraph>
    </section>
    <section id="HBB8C0E79740F499394DEC98937906F15">
      <enum>3.</enum>
      <header>Increasing public
			 awareness of dangers of synthetic drugs through national youth antidrug media
			 campaign</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Office of National Drug Control Policy Reauthorization Act of 1998/s:709">Section 709 of the
			 Office of National Drug Control Policy Reauthorization Act of 1998</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/1708">21 U.S.C.
			 1708</cato:entity-ref>)</cato:entity> is amended—</text>
			<paragraph id="HB7AFA00A59A4417395A1E4F693DE2C83">
        <enum>(1)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Office of National Drug Control Policy Reauthorization Act of 1998/s:709/ss:a/p:3">subsection
			 (a)(3)</cato:entity-ref>, by inserting <quote>and synthetic drug use</quote> after <quote>illegal
			 drug use</quote>; and</text>
			</paragraph>
      <paragraph id="HC140AFCA6EB34DA9A2CC16D1710DD432">
        <enum>(2)</enum>
        <text>by redesignating
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Office of National Drug Control Policy Reauthorization Act of 1998/s:709/ss:l">subsection (l)</cato:entity-ref> as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Office of National Drug Control Policy Reauthorization Act of 1998/s:709/ss:m" proposed="true">subsection (m)</cato:entity-ref> and inserting after subsection (k) the
			 following new subsection:</text>
				<quoted-block id="H4BBB8A8379864E069B08BC3943970BDB" style="OLC">
					<subsection id="H19F2D9F29CD94B308CCAB5815E085F0E">
            <enum>(l)</enum>
            <header>Definitions</header>
            <text>For
				purposes of this section:</text>
						<paragraph id="H1C78056CC190441FB248DABC90D4286F">
              <enum>(1)</enum>
              <header>Drug</header>
              <text>The
				term <quote>drug</quote> has the meaning given such term in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Office of National Drug Control Policy Reauthorization Act of 1998/s:702/p:3">section 702(3)</cato:entity-ref> and
				includes a synthetic drug.</text>
						</paragraph>
            <paragraph id="HD4145B1D96154FF3B2C519B65FF0BD62">
              <enum>(2)</enum>
              <header>Synthetic
				drug</header>
              <text>The term <quote>synthetic drug</quote> means an artificially
				produced substance that, as determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1127">Director</cato:entity-ref>, is an analog or
				derivative of a controlled substance (as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                  <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:102/p:6">section 102(6) of the
				Controlled Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/802">
                    <cato:entity-ref entity-type="uscode" value="usc/21/802//6">21 U.S.C. 802(6)</cato:entity-ref>
                  </external-xref>)</cato:entity>, but is not itself a controlled
				substance.</text>
						</paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</paragraph>
    </section>
  </legis-body>
</bill>
</doc>